v3.26.1
Income Taxes (Tables)
6 Months Ended
Mar. 31, 2026
Income Taxes [Abstract]  
Schedule of Company’s Continuing Operations in China and Consisted

Income taxes for the six months ended March 31, 2026 and 2025 are attributed to the Company’s continuing operations in China and consisted of:

 

   2026   2025 
Current income tax expense  $
-
   $
-
 
Deferred income tax benefit   (201,535)   (85,255)
Total income tax benefit  $(201,535)  $(85,255)
Schedule of Income Tax Expense Reconciliation

Income tax expense reconciliation are as follows:

 

   2026   2025 
(Loss) Income before taxes  $(1,307,264)  $65,530 
PRC EIT tax rates   25%   25%
Tax at the PRC EIT tax rates  $(326,816)   16,383 
Difference due to preferential tax   62,847    (40,266)
Rate differences in various jurisdictions   80,154    73,310 
Tax effect of R&D expenses deduction   (122,856)   (160,183)
Tax effect of non-deductible expenses   15,591    14,529 
Changes in valuation allowance   89,545    10,972 
Income tax expenses (benefits)  $(201,535)  $(85,255)
Schedule of Tax Effects of Temporary Differences that Give Rise to Significant Portions of the Deferred Tax Asset

The tax effects of temporary differences that give rise to significant portions of the deferred tax assets at March 31, 2026 and September 30, 2025 are presented below:

 

   March 31,
2026
   September 30,
2025
 
Deferred tax assets:        
Allowance for expected credit losses  $170,448   $214,752 
Allowance for bad debt   83,976    116,747 
Impairment on long-term investment   181,213    175,588 
Loss carryforward   1,070,672    665,998 
DTA allowance   (223,824)   (128,751)
Total  $1,282,485   $1,044,334 
Schedule of Tax Payables

Taxes payable consist of the following:

 

   March 31,
2026
   September 30,
2025
 
Income tax payable  $3,012,118   $2,918,611 
VAT and tax payable (receivable)   (267,306)   42,562 
Total tax payable  $2,744,812   $2,961,173